Envestnet Asset Management’s St Jude Medical STJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-562
| Closed | -$46K | – | 3227 |
|
|
2017
Q1 | $46K | Sell |
562
-9,429
| -94% | -$761K | ﹤0.01% | 2450 |
|
|
2016
Q4 | $796K | Sell |
9,991
-2,762
| -22% | -$219K | ﹤0.01% | 1280 |
|
|
2016
Q3 | $1.02M | Sell |
12,753
-46,664
| -79% | -$3.77M | ﹤0.01% | 1244 |
|
|
2016
Q2 | $4.63M | Buy |
59,417
+7,290
| +14% | +$520K | 0.02% | 655 |
|
|
2016
Q1 | $2.87M | Buy |
52,127
+2,108
| +4% | +$115K | 0.01% | 816 |
|
|
2015
Q4 | $3.09M | Sell |
50,019
-4,031
| -7% | -$254K | 0.01% | 758 |
|
|
2015
Q3 | $3.41M | Buy |
54,050
+14,350
| +36% | +$1.02M | 0.02% | 720 |
|
|
2015
Q2 | $2.9M | Sell |
39,700
-1,953
| -5% | -$141K | 0.01% | 865 |
|
|
2015
Q1 | $2.72M | Buy |
41,653
+37,968
| +1,030% | +$2.52M | 0.01% | 829 |
|
|
2014
Q4 | $240K | Buy |
3,685
+76
| +2% | +$4.89K | ﹤0.01% | 946 |
|
|
2014
Q3 | $217K | Buy |
3,609
+164
| +5% | +$10.7K | ﹤0.01% | 1066 |
|
|
2014
Q2 | $239K | Sell |
3,445
-268
| -7% | -$17.4K | ﹤0.01% | 951 |
|
|
2014
Q1 | $243K | Buy |
3,713
+380
| +11% | +$24.7K | ﹤0.01% | 847 |
|
|
2013
Q4 | $206K | Sell |
3,333
-264
| -7% | -$15.3K | ﹤0.01% | 821 |
|
|
2013
Q3 | $193K | Buy |
3,597
+4
| +0.1% | +$206 | ﹤0.01% | 805 |
|
|
2013
Q2 | $164K | Buy |
+3,593
| New | +$156K | ﹤0.01% | 842 |
|
Other funds holding STJ
Envestnet Asset Management's STJ Position: Q2 2017 in Review
Envestnet Asset Management sold out of St Jude Medical (STJ) in Q2 2017, closing a stake of 562 shares — an estimated $46K sold.
Envestnet Asset Management first reported a position in STJ in Q2 2013 and held it in 16 quarters. The position peaked at $4.63M in Q2 2016. 1 fund tracked by Wall St. Rank holds STJ as of Q2 2017.
- Envestnet Asset Management reported no remaining St Jude Medical position as of Q2 2017 after selling out during the quarter.
- Envestnet Asset Management sold 562 St Jude Medical shares in Q2 2017, an estimated $46K.
- Envestnet Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 16 quarters.
- Envestnet Asset Management's St Jude Medical position peaked at $4.63M in Q2 2016.
- 1 fund tracked by Wall St. Rank held St Jude Medical as of Q2 2017.
Based on Envestnet Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.